Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial
Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjær, H.; Rådegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.; Gullestad, l.
Journal of Heart and Lung Transplantation 34(4): S129-S130
2015
ISSN/ISBN: 1053-2498 DOI: 10.1016/j.healun.2015.01.346
Accession: 064783444
PDF emailed within 0-6 h: $19.90
Related References
Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Rådegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.; Gullestad, L. 2016: Everolimus Initiation with Early Calcineurin Inhibitor Withdrawal in de Novo Heart Transplant Recipients: Three-Year Results from the Randomized SCHEDULE Study American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(4): 1238-1247Gustafsson, F.; Andreassen, A.K.; Andersson, B.; Eiskjær, H.; Rådegran, G.ör.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.ör.; Gullestad, L. 2020: Everolimus Initiation with Early Calcineurin Inhibitor Withdrawal in de Novo Heart Transplant Recipients: Long-term Follow-up from the Randomized SCHEDULE Study Transplantation 104(1): 154-164
Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Radegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Sigurdardottir, V.; Arora, S.; Dellgren, G.; Gullestad, L.; Christensen, S.B.; Just, C.; Selimovic, N.; Bollano, E.; Bartfay, S.-E.; Karason, K.; Roy, S.D.; Rexius, H.; Janssen, A.; Rosenberg, M.; Persson, L.; Kornhall, B.ör.; Ekmehag, B.ör.; Reitan, Öy.; Stueflotten, W.; Relbo, A.; Grov, I.; Erikstad, I.; Solberg, O.G.; Ragnarsson, A.; Aakhus, S.; Massey, R. 2014: Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14(8): 1828-1838
Van Keer, J.; Derthoo, D.; Van Caenegem, O.; De Pauw, M.; Nellessen, E.; Duerinckx, N.; Droogne, W.; Vörös, G.áb.; Meyns, B.; Belmans, A.; Janssens, S.; Van Cleemput, J.; Vanhaecke, J. 2017: The CECARi Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: a Multicenter, Randomized Trial Journal of Transplantation 2017: 6347138
Arora, S.; Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Bøtker, H.E.; Rådegran, G.; Gude, E.; Ioanes, D.; Solbu, D.; Sigurdardottir, V.; Dellgren, G.; Erikstad, I.; Solberg, O.G.; Ueland, T.; Aukrust, P.; Gullestad, L.; Christensen, S.B.; Just, C.; Tram, E.M.; Mølbak, D.; Selimovic, N.; Bollano, E.; Bartfay, S.-E.; Karason, K.; Roy, S.D.; Rexius, H.; Janssen, A.; Rosenberg, M.; Persson, L.; Kornhall, B.ör.; Ekmehag, B.ör.; Reitan, Øy.; Stueflotten, W.; Relbo, A.; Grov, I.; Ragnarsson, A. 2015: The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in de Novo Recipients: One-Year Results of a Scandinavian Randomized Trial American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(7): 1967-1975
Relbo Authen, A.; Grov, I.; Karason, K.; Gustafsson, F.; Eiskjaer, H.; Rådegran, G.ör.; Gude, E.; Jansson, K.; Dellgren, G.ör.; Solbu, D.; Arora, S.; Andreassen, A.K.; Gullestad, L. 2017: Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE) Clinical Transplantation 31(9)
Andreassen, A. K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Raadegran, G.; Gude, E.; Solbu, D.; Sigurdardottir, V.; Dellgren, G.; Gullestad, L. 2013: Early calcineurin inhibitors avoidance improves renal function in de novo heart transplant recipients: The results of a randomized controlled trial (SCHEDULE trial) European Heart Journal 34(Suppl 1): 879-879
De Simone, P.; Metselaar, H.J.; Fischer, L.; Dumortier, J.ér.ôm.; Boudjema, K.; Hardwigsen, J.; Rostaing, L.; De Carlis, L.; Saliba, F.; Nevens, F. 2009: Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 15(10): 1262-1269
Derthoo, D.; Van Caenegem, O.; De Pauw, M.; Nellessen, E.; Duerinckx, N.; Ciarka, A.; Droogné, W.; Van Cleemput, J.; Belmans, A.; Meyns, B.; Vanhaecke, J. 2014: A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function Journal of Heart and Lung Transplantation 33(4): S14-S15
Rashidi, M.; Esmaily, S.; Fiane, A.E.; Gustafsson, F.; Eiskjær, H.; Rådegran, G.; Dellgren, G. 2015: The Effect of Everolimus vs. Calcineurin Inhibitors on Surgical Complications: The Results of a De Novo Heart Transplant Randomized Controlled Trial (SCHEDULE Trial) Journal of Heart and Lung Transplantation 34(4): S132-S133
Gullestad, L.; Mortensen, S.-A.; Eiskjær, H.; Riise, G.C.; Mared, L.; Bjørtuft, O.; Ekmehag, B.ör.; Jansson, K.; Simonsen, S.; Gude, E.; Rundqvist, B.; Fagertun, H.E.; Solbu, D.; Iversen, M. 2010: Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial Transplantation 90(12): 1581-1589
Maurer, J.R. 2011: Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial Yearbook of Pulmonary Disease 2011: 189-191
Gullestad, L.; Iversen, M.; Mortensen, S.-A.; Eiskjaer, H.; Riise, G.C.; Mared, L.; Bjørtuft, O.; Ekmehag, B.ör.; Jansson, K.; Simonsen, S.; Gude, E.; Rundqvist, B.; Fagertun, H.E.; Solbu, D.; Bergh, C.-H.åk. 2010: Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial Transplantation 89(7): 864-872
Sterneck, M.; Kaiser, G.M.; Heyne, N.; Richter, N.; Rauchfuss, F.; Pascher, A.; Schemmer, P.; Fischer, L.; Klein, C.G.; Nadalin, S.; Lehner, F.; Settmacher, U.; Neuhaus, P.; Gotthardt, D.; Loss, M.; Ladenburger, S.; Paulus, E.M.; Mertens, M.; Schlitt, H.J. 2014: Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14(3): 701-710
Gullestad, L.; Eiskjaer, H.; Gustafsson, F.; Riise, G.C.; Karason, K.; Dellgren, G.ör.; Rådegran, G.ör.; Hansson, L.; Gude, E.; Bjørtuft, Øy.; Jansson, K.; Schultz, H.H.; Solbu, D.; Iversen, M. 2016: Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial Transplant International: Official Journal of the European Society for Organ Transplantation 29(7): 819-829
Andreassen, A.K.; Broch, K.; Eiskjær, H.; Karason, K.; Gude, E.; Mølbak, D.; Stueflotten, W.; Gullestad, L. 2019: Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial Transplantation 103(4): 781-788
Murbraech, K.; Holdaas, H.; Massey, R.; Undset, L.H.; Aakhus, S. 2014: Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial Transplantation 97(2): 184-188
Murbraech, K.; Massey, R.; Undset, L.H.; Midtvedt, K.; Holdaas, H.; Aakhus, S. 2015: Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial Clinical Transplantation 29(8): 678-684
Arora, S.; Solberg, O.; Gustafsson, F.; Karason, K.; Eiskjær, H.; Bøtker, H.E.; Rådegran, G.; Dellgren, G.; Ioanes, D.; Gude, E.; Solbu, D.; Andreassen, A.K.; Gullestad, L. 2016: The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy Assessed by Virtual Histology: Results of the SCHEDULE Trial Journal of Heart and Lung Transplantation 35(4): S16-S17
Solberg, O.Geir.; Stavem, K.; Ragnarsson, A.; Ioanes, D.; Arora, S.; Endresen, K.; Benth, Jūratė.Šaltytė.; Gullestad, L.; Gude, E.; Andreassen, A.K.; Aaberge, L. 2016: Index of microvascular resistance after early conversion from calcineurin inhibitor to everolimus in heart transplantation: A sub-study to a 1-year randomized trial Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 35(8): 1010-1017